Stock-Based Payments (Details) - USD ($) | 3 Months Ended |
Mar. 31, 2021 | Mar. 31, 2020 |
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items] | | | | |
Stock-Based Compensation Expenses | | $ 35,000,000 | | $ 40,000,000 |
Common Shares Available for Grant | | 2,000,000 | | |
Aggregate Maximum of Common Shares | | 20,000,000 | | |
Stock Options And SARs | | | | |
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items] | | | | |
Stock-based compensation expense related to stock options, SAR and ESPP grants | | $ 10,000,000 | | $ 14,000,000 |
Unrecognized compensation expense | | $ 47,000,000 | | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | 1 year 10 months 24 days | | |
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract] | | | | |
Weighted Average Fair Value of Grants (price per share) | | $ 17.03 | | $ 19.67 |
Expected Volatility (in hundredths) | | 47.18% | | 33.43% |
Risk-Free Interest Rate (in hundredths) | | 0.28% | | 1.43% |
Dividend Yield (in hundredths) | | 3.25% | | 1.60% |
Expected Life (in years) | | 5 years 2 months 12 days | | 5 years |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | | | | |
Outstanding at January 1 (in shares) | | 10,186,000 | | 9,395,000 |
Granted (in shares) | | 7,000 | | 9,000 |
Exercised (1) (in shares) | [1] | (26,000) | | (23,000) |
Forfeited (in shares) | | (103,000) | | (47,000) |
Outstanding at March 31 (2) | [2] | 10,064,000 | | 9,334,000 |
Stock Options and SARs Vested or Expected to Vest (3) (in shares) | [3] | 9,749,000 | | 8,998,000 |
Stock Options and SARs Exercisable at March 31 (4) (in shares) | [4] | 6,288,000 | | 5,249,000 |
Intrinsic Value of Stock Options/SARs Exercised | [1] | $ 200,000 | | $ 400,000 |
Intrinsic Value of Stock Options/SARs Outstanding | [2] | $ 71,000,000 | | $ 0 |
Weighted Average Remaining Contractual Life for Stock Options/SARs Outstanding (in years) | [2] | 4 years | | 4 years |
Intrinsic Value of Stock Options/SARs Vested or Expected to Vest | [3] | $ 66,000,000 | | $ 0 |
Weighted average remaining contractual life for stock options/SARs vested or expected to vest (in years) | [3] | 4 years | | 4 years |
Aggregate Intrinsic Value for Exercisable Units | [4] | $ 3,000,000 | | $ 0 |
Weighted average remaining contractual life for exercisable options/SARs (in years) | [4] | 3 years | | 2 years 9 months 18 days |
Weighted Average Grant Price Stock Option and SARs [Rollforward] | | | | |
Outstanding at January 1 (price per share) | | $ 84.08 | | $ 94.53 |
Granted (price per share) | | 53.98 | | 75.44 |
Exercised (1) (price per share) | [1] | 63.25 | | 69.59 |
Forfeited (price per share) | | 89.21 | | 96.81 |
Outstanding at March 31 (2) | [2] | 84.06 | | 94.56 |
Vested or Expected to Vest (3) (price per share) | [3] | 84.74 | | 94.55 |
Exercisable at March 31 (4) | [4] | 96.47 | | 94.33 |
ESPP | | | | |
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract] | | | | |
Weighted Average Fair Value of Grants (price per share) | | $ 14.69 | | $ 20.80 |
Expected Volatility (in hundredths) | | 54.99% | | 35.24% |
Risk-Free Interest Rate (in hundredths) | | 0.09% | | 1.56% |
Dividend Yield (in hundredths) | | 3.41% | | 1.56% |
Expected Life (in years) | | 6 months | | 6 months |
Restricted Stock And Restricted Stock Units | | | | |
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items] | | | | |
Unrecognized compensation expense | | $ 153,000,000 | | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | 1 year 6 months | | |
Share-Based Compensation Arrangement By Restricted Stock And Restricted Stock Units Compensation Cost | | $ 24,000,000 | | $ 25,000,000 |
Restricted Stock/Restricted Stock Units and Performance Units [Roll Forward] | | | | |
Outstanding at January 1 (in shares) | | 4,742,000 | | 4,546,000 |
Granted (in shares) | | 12,000 | | 26,000 |
Released (1) (in shares) | [5] | (430,000) | | (259,000) |
Forfeited (in shares) | | (25,000) | | (11,000) |
Outstanding at March 31 (3) | [6] | 4,299,000 | | 4,302,000 |
Intrinsic value released during the year | [5] | $ 31,000,000 | | $ 11,000,000 |
Aggregate intrinsic value of stock and units outstanding | [6] | $ 312,000,000 | | $ 155,000,000 |
Weighted Average Grant Price Restricted Stock and Restricted Stock Units [Roll Forward] | | | | |
Outstanding at January 1 (price per share) | | $ 74.97 | | $ 90.16 |
Granted (price per share) | | 60.27 | | 63.48 |
Released (2) (price per share) | [5] | 90.27 | | 88.19 |
Forfeited (price per share) | | 71.16 | | 89.86 |
Outstanding at March 31 (3) (price per share) | [6] | $ 73.42 | | $ 90.12 |
Performance Unit | | | | |
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items] | | | | |
Stock-Based Compensation Expenses | | $ 1,000,000 | | $ 1,000,000 |
Unrecognized compensation expense | | $ 7,000,000 | | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | 1 year 10 months 24 days | | |
Restricted Stock/Restricted Stock Units and Performance Units [Roll Forward] | | | | |
Outstanding at January 1 (in shares) | | 613,000 | | 598,000 |
Granted (in shares) | | 8,000 | | 0 |
Granted for Performance Multiple (1) | [7] | 19,000 | | 66,000 |
Released (1) (in shares) | [8] | (98,000) | | (121,000) |
Forfeited (in shares) | | 0 | | 0 |
Outstanding at March 31 (3) | [9] | 542,000 | [10] | 543,000 |
Intrinsic value released during the year | | $ 6,000,000 | [8] | $ 9,000,000 |
Aggregate intrinsic value of stock and units outstanding | [9] | $ 39,000,000 | | $ 20,000,000 |
Weighted Average Grant Price Restricted Stock and Restricted Stock Units [Roll Forward] | | | | |
Outstanding at January 1 (price per share) | | $ 79.10 | | $ 92.19 |
Granted (price per share) | | 49.86 | | 0 |
Granted for Performance Multiple (1) (in dollars per share) | [7] | 96.29 | | 100.95 |
Released (2) (price per share) | [8] | 96.29 | | 104.69 |
Forfeited (price per share) | | 0 | | 0 |
Outstanding at March 31 (3) (price per share) | [9] | $ 76.18 | | $ 90.48 |
Performance Units and Performance Stock Disclosures [Abstract] | | | | |
Performance Period for Performance Units and Shares | | 3 years | | |
Minimum Performance Multiple at the Completion of the Performance Period | | 0.00% | | |
Maximum Performance Multiple at the Completion of the Performance Period | | 200.00% | | |
Performance Multiple Applied at the Completion Period | [7] | 125.00% | | 150.00% |
Minimum Performance Units and Stock Allowed to be Outstanding | [10] | 76,785 | | |
Maximum Performance Units Allowed to be Outstanding | [10] | 1,007,705 | | |
Lease and Well | | | | |
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items] | | | | |
Stock-Based Compensation Expenses | | $ 14,000,000 | | $ 15,000,000 |
Gathering and Processing Costs | | | | |
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items] | | | | |
Stock-Based Compensation Expenses | | 0 | | 0 |
Exploration Costs | | | | |
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items] | | | | |
Stock-Based Compensation Expenses | | 6,000,000 | | 7,000,000 |
General and Administrative | | | | |
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items] | | | | |
Stock-Based Compensation Expenses | | $ 15,000,000 | | $ 18,000,000 |
| |
[1] | The total intrinsic value of stock options/SARs exercised during the three months ended March 31, 2021 and 2020 was $0.2 million and $0.4 million, respectively. The intrinsic value is based upon the difference between the market price of EOG's common stock on the date of exercise and the grant price of the stock options/SARs. | |
[2] | The total intrinsic value of stock options/SARs outstanding at March 31, 2021 and 2020 was $71 million and zero, respectively. At March 31, 2021 and 2020, the weighted average remaining contractual life was 4.0 years. | |
[3] | The total intrinsic value of stock options/SARs vested or expected to vest at March 31, 2021 and 2020 was $66 million and zero, respectively. At March 31, 2021 and 2020, the weighted average remaining contractual life was 4.0 years. | |
[4] | The total intrinsic value of stock options/SARs exercisable at March 31, 2021 and 2020 was $3 million and zero, respectively. At March 31, 2021 and 2020, the weighted average remaining contractual life was 3.0 years and 2.8 years, respectively. | |
[5] | The total intrinsic value of restricted stock and restricted stock units released during the three months ended March 31, 2021 and 2020 was $31 million and $11 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the restricted stock and restricted stock units are released. | |
[6] | The total intrinsic value of restricted stock and restricted stock units outstanding at March 31, 2021 and 2020 was $312 million and $155 million, respectively. | |
[7] | Upon completion of the Performance Period for the performance units granted in 2017 and 2016, a performance multiple of 125% and 150%, respectively, was applied to each of the grants resulting in additional grants of performance units in February 2021 and February 2020, respectively. | |
[8] | The total intrinsic value of performance units released during the three months ended March 31, 2021 and 2020 was $6 million and $9 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the performance units are released. | |
[9] | The total intrinsic value of performance units outstanding at March 31, 2021 and 2020 was approximately $39 million and $20 million, respectively. | |
[10] | Upon the application of the relevant performance multiple at the completion of each of the remaining Performance Periods, a minimum of 76,785 and a maximum of 1,007,705 performance units could be outstanding. | |